References
Thompson N.W., Nishiyama R.H., Harness J.K. Thyroid carcinoma: Current controversies. Curr. Probl. Surg. 15: 1, 1978.
Cady B., Sedgewick C., Meissner W.A. Risk factor analysis in differentiated thyroid cancer. Cancer 43: 810, 1979.
Mazzaferri E.L., Young R.L., Dertel J.E., et al. Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine 56: 171, 1977.
Grant C.S., Hay I.D., Gough I.R. Local recurrence in papillary carcinoma: Is extent of surgical resection important? Surgery 104: 954, 1988.
Levin K.E., Clark A.H., Duh Q.Y. Reoperative thyroid surgery. Surgery 111: 604, 1992.
Tollefsen H.R., Shah J.P., Huvos A.G. Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am. J. Surg. 124: 468, 1972.
Noguchi S., Noguchi A., Murakami N. Papillary thyroid carcinomas of the thyroid I. Developing patterns of metastasis. Cancer 26: 1053, 1970 and Cancer 26: 1061, 1970.
Noguchi S., Noguchi A., Murakami N. Papillary carcinoma of the thyroid. Value of prophylactic lymph node excision. Cancer 26: 1061, 1970.
Goretzki P.E., Lyon J., Stacy-Phipps S. Mutational activation of ras and gsp oncogenes in differentiated thyroid cancer and their biological implications. World. J. Surg. 16: 576, 1992.
Siperstein A., Zeng Q.H., Gum E. Adenylate cyclase activity as a predictor of thyroid tumor aggressiveness. World. J. Surg. 12: 528, 1988.
Fagin J.A., Matsuo K., Karmakas A. High prevalence of this p53 gene in poorly differentiated human thyroid carcinomas. J. Clin. Invest. 91: 179, 1993.
Clark O.H. Predictors of thyroid tumor aggressiveness. Paul Starr Lecture. American Thyroid Association.
Massin J.P., Savoie J.C., Gamier H. Pulmonary metastases in differentiated thyroid cancer. Cancer 53: 982, 1984.
Schlumberger M., Tubiana M., DeVathaire F. Long term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 63: 960, 1986.
Wong J.B., Kaplan M.M., Meyer K.B., Panker S.G. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. Endocrinol. Metab. Clin. North Am. 19: 741, 1990.
Clark O.H. Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer. Ann. Surg. 196: 361, 1982.
Clark O.H., Levin K.E., Zeng Q.H., Greenspan F.S., Siperstein A. Thyroid cancer: The case of total thyroidectomy. Eur. J. Cancer Clin. Oncol. 24: 305, 1988.
Noguchi S., Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg. Clin. North Am. 67: 251, 1982.
Hutter R.V.P., Frazell L, Foot F.W. Elective radical neck dissection: an assessment of its use in the management of papillary thyroid cancer. Cancer 20: 87, 1970.
Harwood J., Clark O.H., Dunphy J.E. Significance of lymph node metastasis in differentiated thyroid cancer. Am. J. Surg. 136: 107, 1978.
Byar D.P., Green S.B., Dor P. A prognostic index for thyroid carcinoma: A study of the EORTC thyroid cancer cooperation group. Eur. J. Cancer 15: 1041, 1979.
Tennvall J., Biorklund A., Moller T. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma with long follow-up. Cancer 57: 1405, 1985.
Mazzaferri E. Diagnosis and management of differentiated thyroid cancer. American Thyroid Association, Tampa, 1993.
Hay I.D. Papillary thyroid carcinoma. Endocrinol. Metab. Clin. North Am. 19: 545, 1990.
Wilson S.M., Block G.E. Carcinoma of the thyroid metastatic to lymph nodes of the neck. Arch. Surg. 102: 285, 1971.
Schlumberger M., Parmentier C., de Vathaire F., Tubiana M. 131| and external radiation in the tratment of local and metastic thyroid cancer. In: Falk S. (ed.), Thyroid Disease. New York, Raven Press, 537, 1990.
Beahrs O.H., Vandertoll D.J. Complications of secondary thyroidectomy. Surg. Gynecol. Obstet. 117: 535, 1963.
Brennan M.D., Bergstralh E.J., van Heerden J.A., McConahey W.M. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin. Proc. 66: 11, 1991.
Mazzaferri E., Young R.L. Papillary thyroid carcinoma: a 10 year follow up report of the impact of therapy in 576 patients. Amer. J. Med. 70: 511, 1981.
DeGroot L.F., Kaplan E.L., McCormick M., Straus F.H. Natural history, treatment, and course of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 7: 414, 1970.
Leper R. The effect of 131-I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 361: 1143, 1973.
Massin J.P., Savoie J.C., Gamier H. Pulmonary metastases in differentiated thyroid carcinoma. Cancer 53: 982, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clark, O.H. Recurrent thyroid cancer. J Endocrinol Invest 18, 167–169 (1995). https://doi.org/10.1007/BF03349734
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349734